SCHEMBL21881759

SCHEMBL21881759

CP(C)(=O)c1cccc(-c2ccc(-c3ccc(-c4nc(-c5ccccc5)nc5c4ccc4ccccc45)cc3)c3ccccc23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP1B1 Q16678 1/20 0.37
ATM Q13315 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
WHR1 P49842 1/20 0.34
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
MAOA P21397 1/20 0.32
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TOP1 P11387 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27242384 0.95 CYP1A1 (0.36) HDAC8HDAC6CYP1A1CYP1A2CYP1B1
SCHEMBL21881890 0.85 MEN1 (0.51) CYP1A2ATMMEN1KMT2AWHR1
SCHEMBL21881887 0.84 L3MBTL1 (0.39) HDAC8HDAC6ATMMEN1KMT2A
SCHEMBL30865645 0.84 L3MBTL1 (0.39) HDAC8HDAC6ATMMEN1KMT2A
SCHEMBL21881758 0.81 ALDH1A1 (0.44) CYP1A2MEN1KMT2AMAPTALDH1A1
SCHEMBL21881757 0.81 TNKS (0.35) ATMMEN1KMT2AWHR1TOP1
SCHEMBL18893034 0.80 ADORA2A (0.38) CYP1A1CYP1A2CYP1B1ATMMEN1
SCHEMBL17279478 0.79 CYP1A1 (0.43) HDAC8HDAC6CYP1A1CYP1A2CYP1B1
SCHEMBL17279586 0.79 CYP1A1 (0.43) HDAC8HDAC6CYP1A1CYP1A2CYP1B1
SCHEMBL17279456 0.79 CYP1A1 (0.43) HDAC8HDAC6CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 HDAC8 4517/4885HDAC6 4655/4885CYP1A1 8/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 HDAC8 4517/4885HDAC6 4655/4885CYP1A1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.